Cash & equivalents decreased 44.0%
Cash & equivalents changed -44.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -44.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed +36.1% from the comparable as-filed period.
Shares outstanding changed -2.2% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Net income changed +28.0% from the comparable as-filed period.
Total assets changed +29.9% from the comparable as-filed period.
Operating cash flow changed +71.2% from the comparable as-filed period.
Revenue changed +34.8% from the comparable as-filed period.
Net income changed +37.0% from the comparable as-filed period.
Shares outstanding changed -0.8% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Total assets changed +34.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.